Bismuth ‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial

Helicobacter, EarlyView.

Source: Helicobacter - October 22, 2018 Category: Gastroenterology Authors: Fernando Mac ías‐García, Iria Bastón‐Rey, Daniel de la Iglesia‐García, Cristina Calviño‐Suárez, Laura Nieto‐García, Juan Enrique Domínguez‐Muñoz Source Type: research